Want to join the conversation?
$FUL said the company is on track to deliver double digit growth in FY16 and that the business performance is positive and is aligned with expectations. In the Americas, $FUL delivered on its commitments, driving sequential volume improvements and keeping 3Q16 volume flat YoverY.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.